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 Basic Notation 
 
𝑃(𝜁)   global distribution 
𝑃(𝜁/)   initial state distribution 
𝜃1,2,3   vector set of dynamic network parameters 
𝑋 = {𝑋7, … , 𝑋9} set of 𝑛 random variables  
𝑋< 	= =𝑋7<,….	, 𝑋9<? set of 𝑛 random variables at time slice 𝑡 
𝐷 =	 {𝐷7, … , 𝐷9} training data 
(𝐵/, 𝐵7, … , 𝐵C)  dynamic Bayesian network (DBN) with 𝑇 time slices  
𝑃(𝑋7, … , 𝑋9)  joint probability distribution of 𝑛 random variables 






A prognostic model is a formal combination of multiple predictors from which risk 
probability of a specific diagnosis can be modelled for patients. Prognostic models have 
become essential instruments in medicine. The models are used for prediction purposes 
of guiding doctors to make a smart diagnosis, patient-specific decisions or help in 
planning the utilization of resources for patient groups who have similar prognostic 
paths. Dynamic Bayesian networks theoretically provide a very expressive and flexible 
model to solve temporal problems in medicine. However, this involves various 
challenges due both to the nature of the clinical domain, and the nature of the DBN 
modelling and inference process itself. The challenges from the clinical domain include 
insufficient knowledge of temporal interactions of processes in the medical literature, 
the sparse nature and variability of medical data collection, and the difficulty in 
preparing and abstracting clinical data in a suitable format without losing valuable 
information in the process. Challenges about the DBN methodology and implementation 
include the lack of tools that allow easy modelling of temporal processes. Overcoming 
this challenge will help to solve various clinical temporal reasoning problems. In this 
thesis, we addressed these challenges while building a temporal network with 
explanations of the effects of predisposing factors, such as age and gender, and the 
progression information of all diagnoses using claims data from an insurance company 
in Kenya. We showed that our network could differentiate the possible probability 
exposure to a diagnosis given the age and gender and possible paths given a patient’s 
history. We also presented evidence that the more patient history is provided, the better 









The medical industry can be thought of as a sequential process of information processing 
events from the initial collection of data, which includes the patient’s history, physical 
examination and tests, a diagnosis is formed and the validated by further observation 
(Reid, Comptom, Grossman, & Fanjiang, 2005). 
Comprehensive data collection and digitization of healthcare systems have created rich 
sources of data. Electronic health records are the largest mode of electronic medical data 
which is recorded at every point of service at a hospital. Although these data would be 
ideal for the study and modelling of disease generally, these data are not available to 
researchers. However, one source of these data, or at least a subset thereof, can be 
obtained from insurance companies. Insurance companies generate these data by 
recording billable interactions captured by the health care system on insured patients. 
 
Though complex and broad, medical insurance claims data provide a unique possibility 
in care-related research. Claims data are considered a vital and powerful source of 
information that supports the decision-making process of health care stakeholders, 
researchers and policymakers regarding various aspects of the healthcare system. 
Claims data usually are a form of administrative data mostly collected by medical 
providers for billing and reimbursement purposes from insurance companies. The data 
have the benefit of following a relatively consistent method of capturing specific 
diagnoses, procedures, and drugs. Since every interaction between a patient and the 
medical system is used to generate a claim, the system creates a massive database of 
patient information which is standardized and formatted. Claims data can be seen as a 
holistic view of the patient’s interactions with the health care system.  
 
The general objective of clinical treatment is to change the clinical condition of a patient 
from a less healthy to a healthier state. Predicting the evolution of the clinical condition 
and future events is a natural part of this process. This process is of particular interest 
in patients’ clinical conditions that change over time due to critical illnesses, chronic 
condition and type of treatment acquired. Prediction of future events by the human 
clinical expert is an uncertain process that is not well understood (Christakis & Lamont, 
2000). A repeatable, formal, evidence-based model becomes highly desirable to improve 
understanding and accuracy and to reduce uncertainty and variability of these 








A prognostic model is a formal combination of multiple predictors from which the risk 
probability of a specific diagnosis can be modelled for patients (SPRAINED study group, 
2018). Prognostic models are increasingly becoming important instruments in medicine. 
These models use patient-specific parameters and risk factors to predict the future 
occurrence or reoccurrence of a specific disease or diagnosis. The models are used for 
prediction purposes of guiding doctors to make smart diagnosis patient-specific 
decisions or help in planning the utilization of resources for patient groups who have 
similar prognostic paths. For a patient with a given set of symptoms, the prognostic 
model translates the interaction variables to an estimate of the risk of experiencing a 
diagnosis within a specific period. In the past, such knowledge was mostly based on 
doctor’s discretion and their experience and professional experience. Prognostic models 
have, therefore, been known to assist medical practitioners to make more accurate 
predictions based on a smart decision model with a broader knowledge base. 
 
Prognostic models utilize the information that is patient-specific and not a disease or 
treatment-related information. The patient-specific information is used to calculate the 
chance of survival and life span of the disease. The model can monitor how the patient 
progresses in the life of the disease from low to high-risk (Cook, 2008). 
 
There are two main categories of prognosis models: These include models at the patient 
population level and models at the individual patient level. Patient population models 
deal with uncovering patterns or discrepancies in cohorts of patients for a particular 
diagnosis, whereas individual patient models are used to formulate treatment paths 
that are unique to the patient. Prognostic models have improved since their inception 
from simple decision trees to guide therapy into deep statistical models built on large 
datasets.  
 
Prognostic models are constructed using historical patient data. This analysis is 
commonly done by applying linear and generalized linear modelling methods. These 
approaches have three limitations, as highlighted by (Verduijn, 2007). 
1. These models apply variable selection before inducing a model. Most of the time, 
this involves excluding many variables that are deemed irrelevant for the 
prognosis. 
2. The resulting models work under the assumption a prognosis is a one-time event 
at a predefined time. As we will discuss later in this thesis, new information about 
the patient’s health is recorded with time, and these models are not able to 
transform and update the prognosis.  
3. The models have fixed roles of predictor variables and outcome variable to the 
attributes involved. This approach has limitation by not taking into account the 
dynamic nature of the health care progression where an outcome now informs 
what is likely to happen tomorrow. 
 





1.2 Network-Based Prognosis Models 
There have been notable advances in the understanding of human diseases as a result 
of the network models. A graph is usually used to represent network-based disease 
progression models. The nodes represent events and edges represents the relationships 
between the events. Every node contains an already predetermined, mutually exclusive 
number of accepted values. These values represent the specific values under 
investigation, such as a diagnosis or believe. The edges show the direct dependencies 
among the nodes. If a directed edge connects node A to node B, then node A is known as 
a parent of node B, and node B is known as a child of node A. An edge connection A to 
B implies that the value at variable B relies on the value at the parent variable A (or 
that B is influenced, or caused, by A). 
 
Many explicit probabilistic model classes have been proposed and analysed, starting 
with a simple path model (Vogelstein, et al., 1988). The list of extensions includes 
oncogenetic trees (Desper, et al., 1999), distance-based trees (Desper, et al., 2000), 
directed acyclic graphs (Simon, et al., 2000) oncogenetic tree mixture models 
(Beerenwinkel, et al., 2005) , conjunctive Bayesian networks and progression networks 
(Farahani & Lagergren, 2013) as well as new methods to infer probabilistic progression.  
 
The modelling disease progression has been vastly applied in lifestyle diseases, for 
example, diabetes (Gao, Bihorel, DuBios, Almon, & Jusko, 2011) Parkinson's disease  
(Vu, Nutt, & Holford, 2012) , Alzheimer's disease (Zhou, Bohlen, Miller, & Unthank, 
2008) and hypertension (Zhou, Shang, Li, Zhou, & Lu, 2012). Most studies have focused 
on one disease, and many researchers have attempted to model multiple diseases and 
their interaction with each other in one network. 
 
(Jeong, Ko, Oh, & Han, 2017) investigated the root causes and risk factors of diseases 
using a network model and insurance claims data. In their network, following the 
standards set by the 10th revision of the International Statistical Classification of 
Diseases and Related Health Problems (ICD-10), the nodes represent diagnoses, and 
the network highlights their interaction. (Jeong, Ko, Oh, & Han, 2017) propose the 
assumption that a prior diagnosis could be a potential risk factor of a subsequent 
diagnosis. The latter allows the calculation of the relative risk (RR) 
𝑅𝑅1→2 = 	
𝑎	 × 	𝑁
𝑏	 × 	𝑐  
 
where 𝑎 is the count of the 𝐷1→2	pair; 𝑏 is the count of pairs having 𝐷1		as a prior diagnosis; 
𝑐 is the count of pairs having 𝐷2		as the subsequent diagnosis; and 𝑁 is the total count of 
all diagnosis-diagnosis pairs.  
 
Relative risk is the ratio of the probability of a diagnosis found in one category compared 
to the probability of the same diagnosis occurring in another group. The diagnoses are 
connected if they exhibited a temporal trend using Bonferroni-corrected Fisher’s exact 
test. The disease progression network (DPN) was modelled with directionality in mind. 
The resulting DPN, which was based on claims data, including 775 diagnoses and 4,100 
relationships between diagnosis pairs (2,464 unidirectional relationships, 1,335 even 
bidirectional relationships, and 301 lop-sided bidirectional relationships) formed by 






Figure 1.1 Network Disease Progression Model Using Claims Data 
In the network, the size of the node is directly proportional to disease incidence. The 
thickness of an edge is proportional to the magnitude of the RR. According to the legend, 
the colours of the edges show the difference between the female RR and male RR. If we 
consider the existing disease networks built using clinical databases, a weighted 
directional network built with explanations of the risk factors such as gender and age 
and the diagnosis progression pairs. Although these models show the relationships 
between diagnoses using claims data, there are some disadvantages in doing so. A 
diagnosis cannot automatically be assumed to indicate a specific disease because 
diagnosis errors exist. However, the early prediction of disease contributes to the 
improvement of survival rate for patients. Therefore, reliable information concerning 
the progression of a disease to other diseases or from low risk to a high-risk level can be 
obtained, and detection time can be shortened significantly. In addition to that, the 
probability of misdiagnosis could be decreased. With a network that highlights the 
global trends that suggest which diagnosis is the next probable step in the progression 
with patients having different risk factors, the network here is potentially a predictive 




the temporal nature of the claims data to create the DPN, time is not modelled explicitly. 
Dynamic Bayesian networks can potentially overcome this shortcoming. 
 
Dynamic Bayesian networks theoretically provide a very expressive and flexible model 
to solve temporal problems in medicine. However, this involves various challenges due 
both to the nature of the clinical domain and the nature of the DBN modelling and 
inference process itself (Zhang, Ma, Xiao, Lin, & Yin, 2019). The challenges from the 
clinical domain include insufficient knowledge of temporal interactions of processes in 
the medical literature, the sparse nature and variability of medical data collection, and 
the difficulty in preparing and abstracting clinical data in a suitable format without 
losing valuable information in the process. Challenges about the DBN methodology and 
implementation include the lack of tools that allow easy modelling of temporal 
processes. Overcoming this challenge will help to solve various clinical temporal 
reasoning problems.  
1.3 Relevant Works Involving DBNs in Medicine 
There are several papers on the use of DBNs or use of claims data in the medical domain 
that aid in several clinical tasks such as diagnosis and prognosis. The models simulate 
medical knowledge explicitly in terms of causes and effects as inferred from the data, 
research from domain experts, and medical papers. They involve problems on a short 
timescale such as prediction of cancer progression and transplant graft survival. Some 
experiments involve simulated data (Zhang, Ma, Xiao, Lin, & Yin, 2019), whereas some 
experiments use real clinical data (Murphy, 2007). Experiments involving simulated 
data can be used to validate the methods, whereas experiments involving real data serve 
as validation and proofs of concepts of these methods’ ability to answer clinical 
problems. 
 
In this section, we only include works involving temporal modelling and prediction in 
the biomedical domain. Dynamic Bayesian networks have been applied in medicine in 
a minimal number of cases. Some of these studies have used simulated data, and some 
have used minimal amounts of real clinical data. Very few studies have used large data 
sets comprised of real patient data. One of the earliest works describing the use of 
Dynamic Bayesian networks in the biomedical domain is by (Andreassen, Hovorka, 
Benn, Olesen, & Carson, 1991). (Andreassen, Hovorka, Benn, Olesen, & Carson, 1991) 
described a combination of dynamic Bayesian networks and differential equations to 
model serum glucose and insulin dosing and applied it to a data set consisting of 12 
patients with insulin-dependent diabetes mellitus. 
 
 
Gao did a significant amount of research on dynamic models in medicine.  (Gao, Bihorel, 
DuBios, Almon, & Jusko, 2011) utilized an ensemble of graphical models with Markov 
chains to find solutions in different medical domains such as neurosurgical intensive 
care unit monitoring ,colorectal cancer management (Date & Darwen, 2002) and palate 
management (McBrien, Owens, Gabbay, Niezette, & Wolper, 1990). DBNs have been 
used to forecast sleep apnea (Shahar, 1999), formulating a treatment path after 
monitoring renal failure patients who are treated using haemodialysis (Christakis & 
Lamont, 2000). In  (Vu, Nutt, & Holford, 2012), they predicted the future progression of 




representing the changes of various complications of the tumour, beginning with those 
with the most adverse effect. A comprehensive prognostic model was able to predict 
future states by showing the treatments and potential changes. In this model, according 
to the domain knowledge, an initial time, a transition interval and the end time was 
chosen as the model’s time slices.  
 
1.4 Aims of Research 
 
This thesis explores the use of medical insurance claims data to model disease 
progression over time using DBNs for prognosis prediction of clients. The specific aims 
are as follows 
 
1. Create a dynamic Bayesian model-based on medical insurance data 
2. Investigate the use of the DBNs to predict patient outcomes 
3. Evaluate the dynamic Bayesian network model mainly using patient-level test 
data 
4. Illustrate the use of dynamic Bayesian networks for temporal prediction of 
diagnosis inpatient 
 
1.5 Research Objectives 
 
1. Create a disease progression model that can model multiple diseases 
simultaneously. 
2. Create a DPN that can make inferences at the patient and population level. 
 
1.6 Outline of Thesis 
 
The literature review in Chapter 1 aimed to provide information to the health care 
system, the medical structure and discuss the issues pertinent to claims data. We then 
introduced prognosis models and how they have been known to assist medical 
practitioners to make more accurate predictions based on a smart decision model with 
a broader knowledge base. We explored literature on network-based prognosis models, 
including a case study of (Jeong, Ko, Oh, & Han, 2017) network. 
 
Chapter 2 presents the literature on the theory of Bayesian networks and dynamic 
Bayesian networks. The steps used to create Bayesian networks were outlined, and 
these ranged from the creating of the structure, the use of the data to calculate 
probabilities, and how inference is performed using the results. Lastly, the use of 
dynamic Bayesian networks for temporal modelling was examined. The information 






Chapter 3 presented the modelling results and examined the different diagnosis 
progressions that are relevant to the research. Paths investigated include variations of 
population and patient-specific inference, risk factors such as age and gender and 
different progressions of a disease given time. Evaluation of the scenarios was done 
using Bnstruct’s inference engine, which provided information on the most influential 
states in the prediction of given any form of evidence. An example of a ― what-if, using 
hypertension as a case study, the scenario was presented, and this showed the full power 
of the dynamic Bayesian network in modelling.  
 






REVIEW OF THEORETICAL FOUNDATIONS 
Introduction 
Bayesian networks (BNs), also known as belief networks, are graphs that belong to the 
family of probabilistic models. Bayesian Networks are a combination of graph theory 
and probability theory. It enables us to model causal and probabilistic relationships for 
many types of causal problems. They were introduced as a knowledge representation 
and inference mechanism under uncertainty using probability theory. They were 
successfully used in different sectors such as in medicine (Spiegelhalter, Franklin, & 
Bull, 1990) forecasting (Verduijn, Peek, Rosseel, & De, 2007)  and speech recognition 
(Zweig & Russell, 1999) amongst others. 
2.1 Bayesian Networks 
BNs can be thought of as a database of knowledge which contains the beliefs about the 
interaction of variables in a system. The importance of such databases is to infer some 
beliefs or make some predictions or processes in the system. It is said that BNs are used 
to propagate beliefs throughout the network when some new information about the 
variables in the network is available. Consider Figure 2.1; this network investigates the 
interactions between diet, obesity, high cholesterol, high blood pressure and heart 
disease. We can infer certain beliefs; for instance, a person’s diet can be used to predict 
the cholesterol levels and the probability of obesity. If a person is vegan, then the 
probability of having high cholesterol is low, which will, in turn, affect the probability 
of heart disease. The latter is what we call belief propagation. The value taken by one 
variable affects the subsequent (related) variables in the network.  
 
The nodes on the graph represent random variables. Each node has a mutually exclusive 
number of values (states or beliefs). These nodes represent the variables of interest for 
a specific belief system such as a disease or a diagnosis. Edges represent direct 
dependencies (or cause-effect relationships) among variables. If a directed edge connects 
node A to node B, then node A is known as a parent of node B, and node B is known as 
a child of node A. An edge from A to B indicates that the value taken by variable B 
depends on the value taken by variable A (or that B is influenced, or caused, by A).  
These relationships are expressed as probabilistic dependencies which are calculated 
through a set of conditional probability matrices. For example, if we have a variable A 
with states {𝑎7	, 𝑎L, … , 𝑎M	} and conditional dependent variable B with states, 
{𝑏7	, 𝑏L, … , 𝑏3}	then the conditional probabilities can be expressed with the conditional 
probability matrix. 
The graphical representation of this distribution is a DAG with two nodes where node 
A is the parent node, and node B is the child node. This DAG visually specifies how the 
random variables depend on each other.  
Formally, a Bayesian network with variables 𝑋 = 	 {𝑋7, . . . , 𝑋9}	consists of: 
1. The network framework that contains the probabilistic dependencies among the 
nodes. 
2. The network parameters which are a set of local probability distributions 




indicates the effect of one node to the next. For variables that do not have any 
parents (i.e. the roots), their prior probability distribution is defined.  
 
If the variables being considered are discrete, the conditional probability matrices are 
represented as conditional probability tables (CPTs). The CPTs define the probability 
or likelihood of a variable being in a particular state, given the state(s) of its parents 
(Baran & Jantunen, 2004). The CPT describes the effect the parent variable has on a 
child variable. If the data is continuous, conditional probability distributions are used. 
The term CPT is used in this research because it only discusses discrete variables.  
 
Let us consider a simple model of five discrete variables: diet, high cholesterol, obesity, 
heart disease and high blood pressure represented by the symbols 𝐷,𝑂, 𝐶, 𝐵𝑃, and 𝐻, 
respectively. Given a person’s diet, they may develop obesity or high cholesterol. The 
probability of Obesity and high cholesterol in the general population are denoted by 
𝑃(𝑂), and 𝑃(𝐶). The probability of obesity given the knowledge of the person’s diet is 
denoted by 𝑃(𝑂|𝐷), and the probability of high cholesterol when we know the person’s 
diet is denoted by 𝑃(𝐶|𝐷). The conditional probabilities of these two conditions (high 
blood pressure and heart disease) given the knowledge of each of these two conditions 









For ease of explanation, we will move forward with the assumption that all the variables 
in the above network are binary, i.e., variables with only two state/cardinalities. If there 
were 𝑛 variables in the model, then the joint probability distribution will require an 
order of 29  probabilities. The latter is computationally expensive, and an optimization 
method is required. It should be noted that the number 29  does not assume 
independence between the variables. Consider a subset of Figure 2.1 which consists of 
the three nodes high blood pressure (BP), high cholesterol (C), and heart disease (H). 
The joint probability of these three nodes is expressed as 




If we assume that high blood pressure and heart disease are conditionally independent, 
then equation (1) can be rewritten as 
 
        𝑃(𝐶, 𝐵𝑃,𝐻) = 	𝑃(𝐶)𝑃(𝐶)𝑃(𝐶)                                                                          (2) 
Hence, we see that conditional independence reduces the number of terms in the joint 
probability distribution from 𝑂(29)	𝑡𝑜	𝑂(𝑛). Nodes that are connected directly to each 
other are necessarily conditionally dependent. However, nodes that are connected 
indirectly may or may not be conditionally independent. The principle of dependence-
separation (d-separation) provides the necessary and sufficient conditions for 
conditional independence in nodes that are connected indirectly. d-separation is a 
criterion for deciding whether a variable A is independent of another variable C, given 




Figure 2. 2 D-Separation 
Consider the three graphs in Figure 2.2. The figure shows three graphs in converging, 
diverging, and sequential configurations, respectively. Two nodes A and C in a graph 
are d-separated, if and only if there is a node B between them such that: 
•  the connection is sequential or diverging, and the value(state) taken by intermediate 
node B is known as shown in Figure 2.2 (b) and (c). 
•  the connection is converging, and neither the value is taken by B, nor any descendant 
of B is known as shown in Figure 2.2 (a). 
Two nodes in a graph are conditionally independent if and only if they are d-separated. 
 
In Figure 2.2(a), we note that variables A and C try to explain the variable B. If variable 
B is known, the variables A and C share the explanation for B, and hence become 
conditionally dependent. For example, if heart disease can be caused by both obesity 
and high cholesterol, if we know whether the patient has heart disease or not, the 
probability of obesity decreases as the probability of high cholesterol increases and vice 
versa, even if we know that obesity and high cholesterol are independent of each other. 
If one were to consider the relationship between these two conditions in the context of 
heart disease, it would lead one to think that these conditions have an inverse 
relationship between them.  
2.1.2 Markov Blanket 
A significant characteristic of Bayesian networks is that we can infer conditional 
dependencies between variables by visually inspecting the network’s graph. To identify 
the nodes with which any node is conditionally independent, we need to identify its 
“Markov blanket”. The Markov blanket of a variable is a combination of its parents, its 






Figure 2. 3 Markov Blanket Network 
In Figure 2.3, the Markov blanket of node 6 comprises the set of parents, children and 
its children's parents indicated by the orange nodes. The nodes in the Markov blanket 
include 2 and 3 as parents, 8 and 9 as children, and 5 and 7 as its children's parents of 
6. The nodes 1, 4, 10 and 11 are not in the Markov blanket of 6; this implies that they 
are conditionally independent of node 6. This decomposition is essential when making 
the probability inference. Inference in the Bayesian networks setting is the task of 
calculating the probability of each state of a node in the network given the value of the 
other variables. 
 
2.2 Dynamic Bayesian Networks 
 
Due to the chronological format of claims data that provides the medical histories of 
patients, temporal abstraction (TA) of claims data aims to abstract and model claims 
data into meaningful higher-level temporal concepts. A variety of extensions to the 
Bayesian networks introduce temporality into the model. Such an extension includes 
dynamic Bayesian networks (DBN), which involves modelling the progress in patients’ 
diagnosis over time using probabilistic distributions between different diagnoses, both 
within and across different time-slices.  
 
A dynamic Bayesian network is a network with the repeated structure of a BN for each 
time slice over a specific interval (Charitos, 2001). A more appropriate term is ‘temporal 
Bayesian networks’, but the term ‘dynamic Bayesian networks’ has received full 
acceptance and more popularity. While a Bayesian network is a static model, 
representing the joint probability distribution at a fixed point, a DBN can represent the 
evolution of a system over time. In particular, DBNs allow for representing variables at 
multiple time points within the same network structure. Besides the static (within slice) 
conditional probabilistic dependencies, DBNs contain additional temporal 
dependencies, which are represented by edges between the time slices. Since variables 
in the model may be discrete or continuous, time itself may be modelled as discrete or 
continuous as well. A representation of a DBN with three discrete time slices is given 





Figure 2. 4 Dynamic Bayesian Network 
 
 
DBNs can be expressed as a tuple (𝐵/, 𝐵7, …	, 𝐵C) where 𝐵/ is a Bayesian network 
showing the initial distribution of the variables in the first-time slice and 𝐵<	𝑓𝑜𝑟	𝑡 > 0 
represents the temporal model for variables in time slice 𝑡 and 𝑡 + 1. DBNs represent 
the change of variable states at different time points where each time step is fixed. 
Edges represent the local or transitional dependencies among variables. Intra-slice 
edges represent the dependencies within the same time-slice as in a TBN. Inter-slice 
edges connect nodes between time slices and represent their temporal evolutions. The 
edges are used to highlight:  
1. the evolution of a variable over time (this link is always present because the value 
of a variable at one time-step affects its value at the next one);  
2. the relationships between different variables over time.  
 
The network structure across the time slices does not change over time, and this 
characteristic is known as time invariance. Therefore, by referring to them as dynamic, 
we describe a dynamic system and not a network that changes structure over time. 
Furthermore, it is assumed that DBNs use the Markovian property: conditional 
probability distribution of each variable at time 𝑡, for all 𝑡 > 1, depends only on the 
parents from the same time slice or from the previous time slice but not from earlier 
time slices. 
 
Consider the DBN diagram of Figure 2.4 
For a given time slice 𝑡, we will use 𝑋< 	= =𝑋7<,….	, 𝑋9<?	to denote the 𝑛	variables of the time 
slice and 𝑃 to denote a joint probability distribution over the variables in 𝑋. 
 
1. The transition probability for a variable 𝑖 in two consecutive time slices:  
 
𝑃[𝑋1(<\7)] = 	𝑃[𝑝𝑎𝑟𝑒𝑛𝑡𝑠<(𝑋1<)]𝑃[𝑝𝑎𝑟𝑒𝑛𝑡𝑠<\7(𝑋1<)].																																		(3) 
 
where 𝑝𝑎𝑟𝑒𝑛𝑡𝑠<(𝑥1<)	denotes the parent set of (𝐵1<) from the same time slice 𝑡, and the 




2. The joint probability distribution (JPD) for 𝑡 consecutive time slices are defined 
by: 
 
𝑃(𝑋7, … , 𝑋<) = 	𝑃[𝑝𝑎𝑟𝑒𝑛𝑡𝑠<(𝑋1<)]																																																							          (4) 
 
In the example of Figure 2.4, an edge is introduced between variables A and B within 
the same time slice to indicate the effect of the A on the B, and between B and C at 
different time slices, indicating that the value is taken by the variable B at a specific 
time 𝑡 will affect the value of variable C at time 𝑡 + 1. As observed, no arc is extended 
from right to left (against the time flow). In order to comply with the direction of time, 
variable interactions could be perceived as causal interactions. 
2.2.1 Learning with Dynamic Bayesian Networks 
In most scenarios, the underlying network structure of a DBN is unknown, and the first 
problem is to be able to infer the structure and the parameters of the network. Bayesian 
networks are able to learn the parameters when given a pre-defined structure or learn 
a structure and the parameters at the same time. The structure and the parameters of 
a DBN can be learned either from data or using expert knowledge. However, it is 
uncommon that both the structure and parameters are learnt from the same data set. 
Both structure and parameter learning can be performed either as unsupervised 
learning, using the information provided by a data set, or as supervised learning, by 
interviewing experts in the fields relevant for the phenomenon being modelled. 
Combining both approaches is common.  
 
There are two methods of learning and inference explored by (Murphy, 2007) they 
include online and offline. ‘Offline’ implies that all the data needed for the model is 
already available. Learning and inference are done with the batch of data. ‘Online’ 
implies that learning and inference are done on a rolling basis. The model is updated as 
soon as more data is available. Retrospective analysis of clinical data is done using 
offline inference, while prospective clinical decision support requires online inference. 
 
2.2.1.1 Structure Learning 
Structure learning for a dynamic network involves learning both the inter-slice and 
intra-slice structures. Intra-slice structure learning is similar to that with static 
Bayesian networks. The intra-slice connections must form a directed acyclic graph. Once 
intra-slice connections are learned, learning inter-slice connections becomes a variable-
selection problem, where the parents of nodes in time slice 𝑡 must be chosen from time 
slice 𝑡 − 1. Two types of structure learning algorithms are available, namely constraint-
based learning and score-based learning. Score-based learning uses predetermined 
scores for specific network substructures to find the structure of the complete model 
that maximizes the score. Constraint-based learning aims to search a model structure 
that satisfies a set of predefined constraints. The Max-Min Hill-Climbing (MMHC) 
algorithm can be referred to as a hybrid, implementing the techniques from both 
Constraint-based and Score-based learning (Tsamardinos, Brown, & Aliferis, 2006). 
 
MMHC combines concepts from constraint-based and score techniques. MMHC learns 




algorithm called the Max-Min Parents and Children (MMPC). The version discussed 
here was proposed by (Tsamardinos, Brown, & Aliferis, 2006). Max-Min refers to the 
section of the algorithm that implements a heuristic approach, while the children and 
parent section show the output of the algorithm. MMPC is consumed by MMHC to 
create the structure of the BN before running a greedy search to show the orientation 







𝑃𝑎𝑟𝑒𝑛𝑡𝑠	&	𝐶ℎ𝑖𝑙𝑑𝑟𝑒𝑛	𝑜𝑓	𝑋	 = 	𝑀𝑀𝑃𝐶(𝑋, 𝐷) 
𝐸𝑛𝑑	𝑓𝑜𝑟 
2. 𝑔𝑟𝑒𝑒𝑑𝑦	ℎ𝑖𝑙𝑙 − 𝑐𝑙𝑖𝑚𝑏𝑖𝑛𝑔	𝑆𝑒𝑎𝑟𝑐ℎ 
3. 𝐼𝑛𝑖𝑡𝑖𝑎𝑡𝑒	𝑎𝑛	𝑒𝑚𝑝𝑡𝑦	𝑔𝑟𝑎𝑝ℎ	𝑎𝑛𝑑	𝑝𝑒𝑟𝑓𝑜𝑟𝑚	𝐺𝑟𝑒𝑒𝑑𝑦	𝐻𝑖𝑙𝑙 −






For every node, the algorithm identifies the set of parents and children for each 
variable	𝑋, after that a greedy hill-climbing search. By starting with an empty graph, 
the search begins by edge addition, deletion, or direction reversal. Whichever action that 
leads to the largest positive change in the scoring function is taken while the search 
continues recursively. It is important to note that a change can reduce the score. In 
order to terminate the algorithm, 15 consecutive changes should be observed without 
an increase over the maximum score ever observed during the search. The structure 
with the maximum score is then returned. 
 
Structure learning need not be a fully automated process. Parts of the structure or the 
entire structure can be manually defined using domain knowledge, and the best 
structure can be chosen from these predefined models using the structure learning 
algorithms (Friedman, 1998). All the models in this dissertation had the structure 
manually defined using general knowledge and medical research. Bayesian networks in 
which the structure is not learnt from the data but is determined using domain 
knowledge are called expert systems.  
 
2.2.1.2 Parameter Learning 
The problem of parameter learning a probabilistic network is stated as follows: 
investigate the most probable parameters 𝜃 that explain the data. Let 𝐷	 =
	{	𝐷7, 𝐷L, … , 𝐷s} be the training data where 𝐷t 	= 	 {	𝑥7[𝑙], 𝑥L[𝑙], … , 𝑥9[𝑙]} consists of 
instances of the Bayesian network nodes. The component 𝜃 represents the set of 
parameters that quantifies the network. Based on a fixed structure, parameters can be 
learned iteratively using expectation-maximization (EM). The EM algorithm is one of 
the frequently used algorithms for both parameter and structure learning in both static 





The expectation-maximization algorithm searches for the maximum likelihood 
parameter estimates in sparse data. It estimates the parameters of a model iteratively, 
beginning from an initial starting point. Each iteration involves an expectation (E) step 
and a maximization (M) step. The expectation step searches the distribution for the 
missing data, given the observed values for the data and the current parameter 
estimates. The maximization step re-calculates the parameters and returns those with 
the maximum likelihood, with the assumption that the distribution returned in the E 
step is accurate. The idea is such that each iteration gets closer to the true likelihood or 
remains constant (if the local maximum has been attained).  
The probability distribution of all nodes can be represented as:  
 
𝑃(𝑋) 	= 	𝑃(𝑋1|𝑝𝑎𝑟𝑒𝑛𝑡𝑠(𝑋1))                                                   (5) 
The algorithm provides each node with a conditional probability table which is denoted 
vector 𝜃. The vector consists of a combination of parameters, say 𝑃1,2,3	, and is defined 
by: 
𝑃1,2,3	 	= 	𝑃(𝑋1 = 	𝑋3|𝑝𝑎𝑟𝑒𝑛𝑡𝑠(𝑋1) = 	𝑋2)                                            (6) 
Where 𝑖 = 1…𝑛 shows all the variables, 𝑘 = 1…𝑟1 describes all possible 
states(cardinality) taken by 𝑋1 and 𝑗 = 1. . . 𝑞1 ranges all possible parent configurations 
of node 𝑋1 .  
 
Algorithm Expectation Maximization EM 
 















									(<7) 	= 	𝐸	(𝑁1,2,3	)	/	𝐸	(𝑁1,3	)	 
6. 𝑡 = 𝑡 + 1	 
𝑈𝑛𝑡𝑖𝑙	𝑐𝑜𝑛𝑣𝑒𝑟𝑔𝑒𝑛𝑐𝑒	(	 1,2,3





Where 𝑁1,2,3	 is the number of events in the database for which the variable 𝑋1 is in state 






2.2.2 Inference with Dynamic Bayesian Networks 
After the structure and parameters of a model are determined, the model can be used 
to predict future events or explain past events, in a process known as inference. 
Inference in a DBN setting refers to the process of computing probabilities of a set of 
variables when given a set of known variables is provided. More specifically, having 
chosen a significant state within a variable, its probability across different time slices 
is calculated. Many of the algorithms used for inference algorithms are temporal 
extensions of those used for static Bayesian networks.  
 
Assuming, 𝑦/:C = 	 {𝑦/, . . . , 𝑦C	} represents the observations up to and including time 𝑡, 
inference in a DBN can be done in three ways, monitoring, prediction, and smoothing 
(Murphy, 2007).  
 
•  Monitoring also is known as filtering, is the task of computing the current belief state 
for a variable 𝑋1 given all data that are available up to and including time 𝑡. To 
achieve this, 𝑃(𝑋1<|𝑦/:<) will be calculated. The latter is used to investigate the current 
state. This concept is illustrated graphically in the figures below. The arrow denotes 
the time instance at which we want to perform the inference. In the shaded area the 
period for which we have data, and in the unshaded area the period in which data is 




•  Prediction, which is the task of predicting a future value at time 𝑡 with all data from 
the previous time slices. The latter shows that the probability 	𝑃(𝑦/:<) needs to be 
calculated given the states that are available of the previous time slices up to time 𝑡. 
Prediction is used to illustrate the effect of the available actions at time 𝑡 on future 




 •  Smoothing, which is the task of computing a belief state in the past at time 𝑡 − 1	 
given all data up to the time 𝑡 (present). Thus, 	𝑃(𝑋(<\7)|𝑦1:<). Smoothing is available 







METHODOLOGY: MODEL BUILDING AND EVALUATION 
 
The dynamic Bayesian network modelling and inference methods described in Chapter 
2 were applied to the claims information of patients over 2-7 years. The data was 
obtained from the electronic claims records of Jubilee Insurance. Before modelling and 
inference, the data was first transformed and abstracted into a format suitable for 
temporal reasoning, while minimizing the loss of information due to these 
transformations. After, various temporal models were constructed to reflect disease and 
diagnosis processes. The tools and algorithms employed for modelling and subsequent 
interrogation of the models are discussed in this chapter. 
 
3.1 Pre-processing 
3.1.1 Definition of Variables 
Ideally, the definition of variables that are relevant to a study and their states should 
be carried out in a formal, well-structured process that involves relevant stakeholders 
or experts in the problem domain (Baran & Jantunen, 2004). However, in this study, 
due to practical limitation and considerations, variables were chosen based on the data 
provided, general knowledge and medical research. 
 
In defining the states of the variables, either a supervised or an unsupervised approach 
is used. If the data is continuous, this process is called discretization. In a supervised 
approach, the states are set by the user after exploratory data analysis, or information 
from experts, policy or literature. In an unsupervised method, a suitable algorithm is 
used to learn and portion the data automatically; the suitable intervals for the 
thresholds being selected are based on statistical analysis.  
 
3.1.2 Data Preparation 
The correctness of any statistical model relies entirely upon the quality of the data fed 
into the model. The quality determines the precision, sensitivity and accuracy of the 
model. In addition to that, the technique used to infer the structure of the model as well 
as the parameters. The quality of training data can determine the success or failure of 
a model or a technique. Some machine learning models, including the DBN, cannot 
consume raw data extracted from the insurance systems directly. A lot of preprocessing 
and translation of the data need to be done. The transformation formats the data in a 
way that the model can consume. 
 
The administrative claims data used for this study were managed using Oracle 
Database and extracted into excel files for analysis using the programming language R. 
Before extracting the claims data, an SQL query was used to combine the relevant 
variables from the respective tables. The process included selecting the IDs of patients 






The data consisted of the following: a patient background and a claims table. Each table 
has various variables that were extracted. They include beneficiary ID, gender, first and 
second diagnosis, age, claim date and risk group. The data spans from the year 2012 to 
2019. The whole sample population includes 25,597 patients whose age span from 2 to 
72 years. There were about 300,000 claim incidence cases recorded. An incidence case 
is a claim entered on the patient’s behalf due to the services rendered by the medical 
institution. An average of 5 – 12 incidences were recorded for each patient. 
 
All probabilistic models can consume variables in a discrete or continuous format. They 
cannot consume free-text variables. The models described in this dissertation require 
discrete data. Claims data was discretized with a standard structure for all the 
variables. The total count of the variables represents the number of nodes in the 
network. A predetermined number of possible values is assigned to each variable. This 
number of possible values is referred to as its cardinality. Consider a continuous 
variable such as age; it can have infinite cardinality (excluding the reality of morality 
in humans) in order to work with it, we have to restrict it to a smaller set of values. The 




For this data set, most variables are discrete variables, and the cardinality is 
predefined. Table 1 shows a sample of the variables and their first five cardinalities and 



































Table 1 Variable cardinalities 
The continuous variable included in the network is the age variable. Equal width or 
equal interval discretization is the most basic method among the various discretization 
methods. The range of the numerical values of the variable of interest was divided into 
the desired number of intervals or bins by dividing the range equally. The width of the 
intervals (i.e., the difference between the lower and upper bounds) was the same for all 
bins. We present the intervals chosen for the age variable using equal interval 















6 Above 60 
Table 2 Age Group Discretization 
3.1.3 Temporal Abstraction 
After the data preparation phase, the data showing the claims nodes in the model were 
saved in a de-normalized data table. However, the data rows for each patient may differ 
by days, weeks, months or even years. The latter is because patients do not visit the 
doctor in any regular pattern. The latter can produce a very sparse longitudinal table. 
This can be mitigated by temporally consolidating the data. The latter can be done by 
choosing one data point for each time interval represented in the model. The latter will 
reduce the need for performing imputation on our dataset. In our case of the insurance 
claims data set, the hospital visits were not in any particular interval. Hence, a good 
starting point was to abstract the data to select a time interval measurement such as 
yearly or monthly and select a diagnosis within that period as a representative of the 
entire time slice.  
 
During this process, we encountered a case of both multiple records and no records 
observed during each chosen time-slice. The presence of missing data can be attributed 
to the following: there were no claims in that period; the claims were recorded and then 
lost. It may also mean that the client has a medical claim but did not use insurance to 
cater for the bill. In such cases, there are different approaches discussed to mitigate 
this. (Little & Rubin, 1987) refined the causes of missing data as missing at random 
(MAR), missing but completely at random (MCAR) and not missing at random (NMAR) 
(Little & Rubin, 1987). They discuss methods for dealing with missing data which apply 
to the clinical domain, including creating a discrete state for the clinical variable to 
represent missing data, or creating a separate proxy variable for each clinical variable 
to represent missing data. 
 
No special treatment was implemented for missing data in this experiment. The R 
package Bnstruct (Franzin, Sambo, & Camillo, 2017) was used for model building and 
inference. This package implements all the algorithms we needed for model supported 
parameter learning with missing values by imputation. Basic imputation was 
performed using the k-Nearest Neighbor algorithm. The number of neighbours used was 
done by specifying a K value. However, in the case of multiple entries, a representative 
claim was chosen. 
 
Several approaches on how to select the representative claim if there are multiple data 
points in a longitudinal data set are highlighted by several authors, including (Liao, 
2005) . Basic approaches include calculating the mode (which is usually the mode for 
categorical variables) or choosing the unique measurement. In this paper, we decided to 




different from the prior diagnosis. In this manner, we were able to have a temporally 
abstracted data with a null value in the case of missing data points and one claim in the 
case of multiple claims. 
 
3.2 The Model 
3.2.1 Network Construction 
Creating a dynamic Bayesian model consisted of three steps: defining the nodes, 
defining the edges, and defining the states of the nodes. The structure of the models 
used in all the experiments described in this dissertation is based on domain knowledge 
gathered from medical literature. Structure learning algorithms are not used. The 
structure is based on the knowledge that chronic diseases that progress slowly are 
among the most common, expensive, and debilitating of all health problems and patient 
history are very important to be able to show the current risk areas of a patient. 
Therefore, the network proposed here takes the initial diagnosis and uses it to calculate 
the current and future state of the patient. 
 
We first begin by modelling the nodes in the DBN. We then define the states based on 
the output from the discretization algorithm for the continuous variable and the 
categories for the categorical variables. Finally, the edges are defined. Intra-slice edges 
are defined first, followed by inter-slice edges 
 
Initially, the variables contained categories encoded using characters, as shown in the 
previous section. The latter was changed by encoding the categories using integers in 
preparation of feeding it into the network. The table below contains the cardinality of 







risk group 17 
Table 3 Variable summary 
The following variable naming convention was used to distinguish the variables at 
different time slices: each variable will contain an extension of t where 𝑡 indicates the 
time slice. For example, the initial time slice the variable GENDER in the network was 
denoted as GENDER_0. 
 
Bnstruct allows for layering of the nodes. Variables can be grouped in (numbered) 
layers, and a variable can only have parents in upper layers or from the same layer. In 
the learning step, the layering needs to be determined and fed into the model first. The 
first layer contains variables with no parents, and variables in layer 𝑗 can have parents 
only in layers 𝑖	 ≤ 𝑗. Nodes GENDER and AGE were encoded as layer 1 because they are 
risk factors. The DIAGNOSIS node is predefined as layer 2, while RISK GROUP and 




arranged such that parent nodes are those from the next layer above. However, when 
initializing the inter-slice edges, this rule is relaxed, and nodes are allowed to have 
parents from any layer from a previous time slice while having the same restriction 
within its time slice.  
 
 The structure of the model is presented in Figure 3.1.  
 
 
Figure 3. 1 Prognosis Dynamic Bayesian Network 
 
The associated decomposition of the joint probability distribution that is expressed by 
the network is given as 
 
𝑃(𝜁) = 𝑃(𝜁/) ⋅ 𝑃(𝜁7) ⋅ 𝑃(𝜁L) ⋅ 𝑃(𝜁)                                                                        (7) 
where 
𝑃(𝜁/) = 𝑃(𝐴/, 𝐺/, 𝐷/, 𝑅/) 		= 𝑃(𝐴/)	𝑃(𝐺/)	𝑃(𝐴/: 𝐺/)𝑃(𝐷/)																																															 (8) 
𝑃(𝜁7) = 𝑃(𝐷/, 𝑅/, 𝐴7, 𝐺7, 𝑅7, 𝐷7) = 𝑃(𝐴7)	𝑃(𝐺7)	𝑃(𝐷/: 𝑅/: 𝐴7: 𝐺7)𝑃(𝐷7)																							 (9) 
𝑃(𝜁L) = 𝑃(𝐷7, 𝑅7, 𝐴L, 𝐺L, 𝑅L, 𝐷L) = 𝑃(𝐴L)	𝑃(𝐺L)	𝑃(𝐷7: 𝑅7: 𝐴L: 𝐺L)𝑃(𝐷L)																				 (10) 
𝑃(𝜁) = 𝑃(𝐷L, 𝑅L, 𝐴, 𝐺, 𝑅, 𝐷) = 𝑃(𝐴)	𝑃(𝐺)	𝑃(𝐷L: 𝑅L: 𝐴, 𝐺)𝑃(𝐷)																				 (11) 
 
(𝜁/) is the initial state distribution, 𝑃(𝜁7) the transition model, 𝑃(𝜁L) is a sensor model, 
and also, the transition model to	𝑃(𝜁L), which is the final sensor-observation model. 
 
3.2.2 Network Properties 
Two network structures are equivalent if the set of distributions that can be represented 
using one of the structures is identical to the set of distributions that can be represented 
using the other (Chickering, 2002). An equivalence class refers to nodes that have the 
same set of parameters, which means that the structure of the conditional probability 
tables is similar. The parameters, in this case, are said to be ‘tied’. Parameter tying is a 
benefit of the Markov property by assuming the model to be a homogeneous Markov 
chain, i.e., the structure of the conditional probability tables does not change over time. 
If a given node in a time slice and its cohort in a previous or subsequent slice have the 
same set of ancestors, then they are considered to be in the same equivalence class; if 
not, they are then in different equivalence classes. Hence, for a model with 𝑛 nodes per 
time slice in two time slices, the maximum number of parameters (conditional 
probability tables) to be learned is 2𝑛, which is the number of nodes in the two-time 
slices. However, if there are 𝑚 equivalence classes in the first time slice, and 𝑚 ≤ 𝑛, 
then the total parameters needed to describe the model is 2𝑛 −𝑚, since these nodes in 






Figure 3.2 shows the model with the equivalence classes identified.  
Different equivalence classes are shown using different colour schemes. At 𝑡/ four 
equivalence classes are representing each node. Three nodes in the first time slice and 
three nodes all the subsequent time slices are in the same equivalence classes. As shown 
in figure 3.2, this model has only 5 equivalence classes. The distribution of 
DIAGNOSIS_0 is 𝑃(𝐴/: 𝐺/)	while the distributions at DIAGNOSIS _1, DIAGNOSIS _2 
and DIAGNOSIS _3 are 𝑃(𝐷/: 𝑅/: 𝐴7: 𝐺7) ≈ 	𝑃(𝐷7: 𝑅7: 𝐴L: 𝐺L) ≈ 𝑃(𝐷L: 𝑅L: 𝐴: 𝐺) 
respectively.  
During training, Bnstruct automatically unrolls (repeats the network structure) the 
DBN for all the time slices. The structure of the nodes and edges are repeated, and the 
parameters (conditional probability tables) are shared from the second until the last 
time slice. Hence, for a model with 𝑡 timeslices and 𝑛 nodes per time slice, instead of 
having 𝑡𝑛 parameters, we have 𝑡𝑛	– (𝑡 − 1)𝑚	 parameters to learn. In addition to the 
reduction in complexity, parameter tying also helps to support training with an 
arbitrary number of time slices, and a data set where each case (patient) has data with 
a different number of time slices. The latter provides support for real clinical data where 
different patients have different lengths of claims, and hence data sets of different 
temporal lengths.  
 
It is challenging to present the whole network with all of its parameters: The nodes have 
several states, and some CPTs consist of 4 dimensions. An overview of the nodes and 
model structure will, therefore, be given beforehand. As an example, the final network 
and the results obtained for the diagnosis of Hypertension are illustrated in Figure 3.4. 
 
Since the risk factors for diagnosis are age and gender, these nodes can be seen in every 
time slice. Although we do not anticipate that the gender of a patient will change from 
𝑡/ to 	𝑡7, age is allowed to change. The age variable here was calculated from the patients’ 
date of birth and the time of the claim. As the data provided is historical data of up to 6 
years we anticipated that the patient's age would change with time and therefore we 
can see that the prior probabilities of the age groups change slightly from one time slice 
to the next. Consider the age group 5 (50-59) in Figure 3.4. The representation changes 
gradually.  
 
The two nodes, AGE and GENDER, are what we characterized as layer 1, this means 











Figure 3.3 Hypertension BN Network Conditional Probability Table
At the diagnosis level, layer 2, we have an interaction of inter-slice and inter-slice edges 
and can be seen in the structure of the conditional probability tables. At the node 
DIAGNOSIS_0, this is the first diagnosis that the patient claimed. The latter is not 
forgetting that the patient could have been receiving treatment without claiming but 
for the longitudinal extrapolations of the patient’s diagnosis progression, we will assume 
that this is the first sight of the diagnosis. At this node, we have over 200 diagnoses 
observed and as we can see from the model the parents to this node are Age and Gender. 
Therefore, the investigation done at this node is the probability of being diagnosed with 
a specific disease given one’s risk factors. 
 
3.3 Inference  
As discussed in chapter 1, prognosis models have two applications, one is at the 
population level, and one is at the patient level. To demonstrate the kind and level of 
inference that can be conducted at a population level, we pick one diagnosis and 
investigate the population associated with that diagnosis. The selected diagnosis for this 
demonstration is hypertension. For a demonstration of inference at the patient level, 
the most probable diseases for various combinations of the risk factors (Age and Gender) 
are examined. 
 
3.3.1 Inference: Population-Level  
Patient population prognosis models focus on recognizing trends or discrepancies in 
groups of patients for a specific criterion. At the population level, let us look at Figure 
3.5, which is associated with the diagnosis of hypertension. For both male and female, 
the majority of the patients with this diagnosis are between the age of 40 and 59. An 
important observation is that the second age group with the highest proportion in 
females is the Above 60 cohort, while for males it is the 31-40 cohort. From the 
population we have, it appears that females tend to develop hypertension later than 
men. The conclusions drawn above are taken from node DIAGNOSIS_0 which is the 
node that provides the initial distribution of patients with the various diagnosis classes 




Figure 3. 4 Hypertension Age Group Distribution  
Let us consider renal failure; the initial population distributions for male and female 




are different. A more significant portion of the younger population seems to be affected 
by Renal Failure than Hypertension. Intuitively this makes sense as one would expect 
more adult people to suffer from high blood pressure-related diseases  
 
Figure 3. 5 Renal failure Age Group Distribution 
The dynamic nature of the model allows for inference at the population level beyond just 
the initial distribution	𝑃(𝜁/). The progression of the disease over time and its interaction 
with other diagnoses can be inferred. We are going to look at the population of patients 
who were diagnosed with hypertension at any point. We demonstrate how DBNs can be 
used to investigate how other diagnoses interact with patients that have hypertension 
across the time slices.  
Figure 3.7 shows the temporal extrapolation of patients who have been diagnosed with 
hypertension at any point in time and the interaction with diabetes and renal failure. 
These two diagnoses were found to be most prevalent within patients with hypertension. 
This observation can be verified in medical journals such as (World Health 
Organization, 2005) which draw a direct relationship between these three diseases.  
 
We can observe that patients within the age of 0-19 have a very low probability of having 
any of the above diseases, however, from the age of 20-29, in Females, the probability of 
contracting hypertension increases, and it actively interacts with renal failure. In 𝑡, all 
of the patients seemed to suffer from renal failure. In male patients, the graph shows 
that the patients mostly have diabetes and have a low probability of hypertension or 
renal failure compared to their female counterparts. All the following graphs describe 
the interaction between the disease and how they affect the different genders and age 
groups. The graphs give 𝑃(𝐴1/: 𝐺1/) at time slice 0 and 𝑃[𝐷1(<\7): 𝑅1(<\7): 𝐴1<: 𝐺1<] at the 





















Figure 3. 6 Hypertension Time Series Analysis 
3.3.2 Inference: Patient-Level 
Individual patient prognosis models are used to govern treatment advice and provide 
patient-centred consultation. At 𝑡/, the needed risk factors are just the age and gender 
of a patient, and we can be able to predict the prior probabilities of any diagnosis; 
𝑃(𝐴/1: 𝐺/1). When we consider a patient at 𝑡7,we have more than just the risk factors, and 
we have previous diagnosis and risk category at 𝑡/	, 𝐷/	and 𝑅/	respectively from the 
initial distribution which will be used to update the network for belief propagation and 
get a more accurate result in the subsequent time slices.	 
 
Consider a 50-year-old male patient at time slice 0. Table 4 shows the four most probable 
diagnosis based on the risk factors provided only; 𝑃[𝐴/(/): 𝐺/M]. 
 
State Diagnosis Probability 
90 Hypertension 0.22960292 
52 Diabetes 0.12155565 
87 HIV 0.07428497 
126 Renal failure 0.05402610 
Table 4 Prior probabilities for a 50-year-old male patient 
If we consider a different patient with different risk factors such as a 30-year-old female, 
table 5 shows the four most probable diagnosis based on the risk factors provided only; 
𝑃[𝐴/(/): 𝐺/]. As we can note, this patient has a risk of different diseases and different 
probabilities from the first one. This patient-level analysis becomes better as we 








State Diagnosis Probability 
20 Breat Cancer 0.11703255 
90 Hypertension 0.11703255 
87 HIV 0.06301904 
220 Ulcers 0.05401679 
Table 5 Prior probabilities for a 30-year-old female patient 
At time slice 1 we have our first interaction with the inter-slice and intra-slice edges. 
Node diagnosis_1 has four parents, and they include Gender_1 and Age_1 intra-slice 
edges meaning they belong to the same time, DIAGNOSIS_0 and Risk Group_0 as inter-
slice edges which means that they are from the previous time slice. This node can be 
used to calculate 𝑃(𝐷/1: 𝑅/1: 𝐴71: 𝐺71)	the probability that a patient has a specific diagnosis 
given the risk factors at 𝑡7	and the previous diagnosis and risk grouping from the initial 
state distribution, amongst other things. As a demonstration of the kind of inference 
that can be performed at this node, we investigated three questions: 
1. What is the probability of suffering from a specific disease, diabetes, given a 
similar diagnosis at 𝑡/ the first time slice?  
2. The probabilities associated with the subsequent diagnosis given the diagnosis 
observed in the first time slice. For example, if a patient has diabetes in the first 
time slice, what are the most probable subsequent diagnosis at 𝑡7,?  
3. If a patient is diagnosed with diabetes in time slice 2, 𝑡7, what did they suffer 





As we discussed for time slice 0, all the Conditional Probability Tables (CPTs) are 
decomposed to the gender and age group, therefore, to answer the questions above, we 
compared the different results concerning the risk factors. The questions respectively 
relate to the inference tasks of monitoring, prediction and smoothing. 
 The table below, Table 6, shows the probability of the second diagnosis being diabetes if the 
prior diagnosis was also diabetes. This table answers to question 1. This question is able to show 
how different gender and age groups deal with disease progression. Although we are tracking 
the same disease from t0 to t1 we investigate how different groups move within the same 
diagnosis. The subsequent questions 2 & 3 tackle interaction with other diagnoses 
 
              Age           
Gender 
Female Male 
0-10 1.631087e-06 0.999636268 
11-20 0.6665860 0.499909458 
21-30 5.438282e-07 0.374983072 
31-40 0.4999095 0.199992853 
41-60 0.3333200 0.277772228 
Above 60 0.0044642 0.004464286 
Table 6 Probability of having diabetes in t1 given a diabetes diagnosis in t0  
To answer question 2, table 7 below shows the most probable diagnosis in 𝑡7 given that 




60, male and female. This analysis can be used to conclude that diabetes can cause 
hypertension in male within age group 41-60, 11.11% of the time while in females 
22.22% of the time. The table also highlights that diabetes in t0 can cause coronary heart 
disease, blindness and low vision in male patients and asthma, renal failure in female 






Diagnosis Probabilities  State 
number 
Diagnosis Probabilities 
62 Diabetes 0.27777223  62 Diabetes 0.3333200 
97 Hypertension 0.11110895  97 Hypertension 0.2222134 
30 Blindness and 
low vision 
0.05555452  19 Asthma 0.1111068 
42 Coronary heart 
disease 
0.05555452  145 Renal failure 0.1111068 
Table 7 Diagnosis probabilities in t1 for a Male in Age group 5 (left) Female Age group 5 (right) 
 
Finally, table 8 below answers question 3 showing the major causes of diabetes in 𝑡7. 
The table shows the probabilities for the age group 41-60, female and male. This 
analysis can be used to conclude that the diagnosis of epistaxis and pneumonia in 
females and Retinal disorders and Hyperglycemia in males are the most likely initial 




Diagnosis  Probabilities  State 
number 
Diagnosis  Probabilities 
68 Epistaxis 0.9996363  175 Retinal disorders 0.9996363 
 












Table 8 Diagnosis probabilities in t0 for a Female in Age group 5 (left) Male Age group 5 (right) with diabetes in t1 
3.3.3 Model Evaluation 
In this section, we are going to infer the diagnosis of a patient at 𝑡7,𝑡L and 𝑡	given 
various amounts of information on the prior variables. The latter should give some kind 
of indication of the usefulness and performance of the dynamic Bayesian models in 
general and the one constructed in this thesis in particular. 
 
 Table 9 below shows 5 patients as a sample of the inference. It shows the initial 
diagnosis and the predicted diagnosis at 𝑡7, 𝑡L	𝑎𝑛𝑑 𝑡 given just the information from 
time slice 𝑡/. The green diagnoses are observed from the data while the rest time slices 
were omitted, and the inference was made. The blue diagnoses were correctly predicted 




43%, 32% and 0% for the time slices 𝑡7, 𝑡L	𝑎𝑛𝑑 𝑡 respectively. The latter gives an average 
prediction accuracy of 29%. 
 
Gender A 𝑡/; 𝐷/1|𝑦/:/ 𝑡7; 𝐷71|𝑦/:/ 𝑡L; 𝐷L1|𝑦/:/ 𝑡; 	𝐷1|𝑦/:/ 
Female 5 52 Diabetes 62 Diabetes 52 Diabetes 73 Diabetes 
Female 5 52 Diabetes 62 Diabetes 52 Diabetes 73 Diabetes 
Female 5 87 Hypertension 97 Hypertension 89 Hypertension 109 Hypertension 
Male 4 87 Hypertension 97 Hypertension 89 Hypertension 109 Hypertension 
Male 4 102 Liver failure 112 Liver failure 107 Liver failure 128 Liver failure 
Table 9 Diagnosis predictions on t1  
The inference was also made with evidence from 𝑡/	𝑎𝑛𝑑	𝑡7 and predict the outcome at 𝑡L	 
and 𝑡 was predicted. The results of this experiment are given in table 10. The prediction 
accuracy for this run was 63% at both time slices.   
 
 
Gender A 𝑡/; 𝐷/1|𝑦/:/ 𝑡7; 	𝐷71|𝑦/:7 𝑡L ; 𝐷L1|𝑦/:7 𝑡; 	𝐷1|𝑦/:7 
Female 5 52 Diabetes 97 Hypertension 89 Hypertension 109 Hypertension 
Female 5 52 Diabetes 62 Diabetes 52 Diabetes 73 Diabetes 
Female 5 87 Hypertension 92 HIV 84 HIV 106 HIV 
Male 4 87 Hypertension 62  Diabetes 80 Glaucoma 73 Diabetes 
Male 4 102 Liver failure 112 Liver failure 107 Liver failure 97 GERD 
 Table 10 Diagnosis predictions on 𝑡L	and 𝑡 
The inference was also made with evidence from three-time slices, and the outcome 
predicted at 𝑡. The results for the sample of patients for this run are displayed in table 
11. The prediction accuracy here was 81%. 
  
 
Gender A 𝑡/; 𝐷/1|𝑦/:/ 𝑡7; 𝐷71|𝑦/:7 𝑡L; 𝐷L1|𝑦/:L 𝑡; 	𝐷1|𝑦/:L 
Female 5 52 Diabetes 97 Hypertension 134 Migraine 109 Hypertensio
n 




Female 5 87 Hypertension 92 HIV 84 HIV 106 HIV 
Male 4 87 Hypertension 62  Diabetes 80 Glaucoma 73 Diabetes 
Male 4 102 Liver failure 112 Liver failure 107 Liver failure 97 GERD 
Table 11 Diagnosis predictions on 𝑡 
 
The series of tables, 9, 10 and 11 show that with more evidence, the predictions are more 
accurate. It is, however, essential to note that although the prediction at any time may 
be wrong, the diagnosis presented here is the state with the highest probability. There 
may be other diagnoses with significant probabilities that could be considered for any 
given patient at any given time. For example, although the last patient’s diagnosis at 
𝑡	is incorrect, when inspecting the CPTs the correct diagnosis, liver failure, had the 
second-highest probability. 
DISCUSSION OF RESULTS AND CONCLUSIONS 
4.1 Discussion 
Chapter 3 presented the modelling results and examined the different diagnosis 
progressions that are relevant to the research. Paths investigated include variations of 
population and patient-specific inference, risk factors such as age and gender and 
different progressions of a disease given time. It is scarce to find a model that can 
perform a wide range of inference, like the one presented in this paper. Some models 
focus on performing inference on a population level and others strictly at the patient 
level. Evaluation of the scenarios was done using Bnstruct’s inference engine, which 
provided information on the most influential states in the prediction given any form of 
evidence. An example of a ―what-if analysis, using hypertension as a case study, was 
presented and this showed the full power of the dynamic Bayesian network as a tool for 
building flexible prognostic models capable of a wide range of inference.  
 
Main findings 
4.1.1 Population Inference 
From the network, we have demonstrated that DBNs can be used to follow diagnoses in 
patients with chronic diseases successfully. The model can find patterns and 
associations of chronic diseases and follow populations. We were able to determine the 
probability of any diagnosis over time for the different risk groups. For instance, we 
were able to highlight the population of hypertension and discover the associated 
diagnosis within the patients and probabilities of shifting between one to the other. This 
information is valuable, specifically for the medical practitioners; it can help to identify 
possible diagnoses and take the necessary steps such as tests to confirm the diagnosis 
and take the appropriate treatments. The detection time could be shortened 
considerably, and the likelihood of misdiagnosis could be decreased. 
 
This information is also suitable for the insurance company for planning and enrolment 
on the wellness program. By planning, the company can be used to predict which chronic 
diseases a patient is at risk. In order to know the cost to sustain each diagnosis, it can 
be possible to plan or generate special premiums associated with the specific care 
needed by such patients. Besides planning financially, Jubilee insurance has a wellness 
program that targets patients with chronic diseases such as hypertension, diabetes and 
heart failure. The wellness program has targeted activities, treatments and remedies 
that help patients cope/live with specific diseases and sometimes prevent or cure them. 
Given a patient’s history, we can be able to predict if a patient will likely develop a 
specific disease and take the necessary precautions to prevent it in accordance with the 









4.1.2 Patient-Level Inference 
The model was able to predict the outcome of a diagnosis given different levels of 
evidence. Given the initial distribution at 𝑡/ the model predicted the diagnosis at the 




Table 12 Diagnoses accuracy given 𝑡/	as evidence 
 
Given the data in 𝑡/	and 𝑡7 as evidence, the inference performed on the subsequent time 
slices yielded the accuracy found in table 12. 
𝑡L 56% 
𝑡 49% 
Table 13 Diagnoses accuracy given 𝑡/	𝑎𝑛𝑑	𝑡7	as evidence 
Given 𝑡/, 𝑡7	𝑎𝑛𝑑	𝑡L the accuracy in predicting the diagnosis at 𝑡	improves to 63.45%. We 
can, therefore, conclude that the more evidence the model has, the better the accuracy 
of the predictions. 
The accuracy calculated here is extracted as the diagnosis with the highest probability. 
For each instance, if we extract the three most probable diagnosis from the model, the 
accuracy of the model changes as was discussed in chapter 3.  
This model may be suitable for use in the real-world clinical setting for early detection 
of chronic diseases if it overcomes the following limitations: 
1. The diagnoses included at 𝑡/ are not necessarily the inception of the patient’s 
medical history and may have, therefore captured a patient’s progress halfway or 
even in its late stages. Though the progress is also very crucial to follow, it is 
instrumental in having a higher percentage of the data to capture with the 
complete chronological order of the patients’ progress. 
2. In order to ensure the validity and accuracy of the model, more patients for each 
of the diagnosis needs to be captured and tracked over a more extended time 
period. As can be noted from the data, some diagnosis like neutrophilia has been 
recorded a handful of times. The latter leads the model to be inaccurate when it 
comes to inference related to that diagnosis. 
4.2 Conclusions 
Dynamic Bayesian networks generalize a large class of probabilistic temporal reasoning 
techniques that include hidden Markov models and Kalman filter models. DBNs provide 
a powerful formalism to perform learning and inference with models that have complex 
causal probabilistic relationships within and across instances of time. 
Pathophysiological processes and clinical practice workflow are inherently temporal 
processes. The complexity of medical science and the practice of medicine prompt the 
need for clinical decision support tools that can help with temporal modelling and 
prediction. Dynamic Bayesian networks are an ideal candidate for application in the 
medical domain to address these challenges. 
 
Despite the success of DBNs and related techniques in other fields such as engineering, 





not been used to a significant extent in clinical medicine. Challenges to their adoption 
include the difficulty in modelling clinical processes using a temporal model, creating 
the model structure, data aggregation, consolidation and discretization, support for 
variable-length temporal processes, learning and inference with missing data, and ease 
of data binding for learning and inference. These are the challenges that motivated this 




4.2.1 Contributions of Research 
 
The research contributed to and explored various aspects of using Dynamic Bayesian 




We explored and described the structure of the model with discrete variables including 
the nodes, edges, and the states of the model. The nodes and edges can often be 
discovered from medical literature or by interviewing clinicians. We described with 
evidence the need to avoid conditional independence and d-separation issues and how 
to solve these issues. 
 
Temporal Data Aggregation, Consolidation, and Abstraction: 
Temporal data aggregation and consolidation techniques were also explored. We 
described data preparation techniques that can be generalized to temporal reasoning 
problems in medicine. We described methods that can be used to aggregate and 
consolidate clinical temporal data from many different data sources into a uniform 
denormalized relational database table. We then described a method to perform 
temporal abstraction to select a representative data point for each time interval. 
 
Diagnosis Progression Modelling Using Claims Data: 
A temporal network within built explanations of the effects of risk factors such as gender 
and age and previous diagnoses was explored. We showed that our network could 
differentiate the possible probability of exposure to a diagnosis given the age and gender 
and possible paths given a patient’s history. We also presented evidence that the more 
patient history is provided, the better the prediction of future diagnosis. We were able 
to conclude that if reliable data on the disease progression to other diagnoses within 
each age group and gender was captured, the diagnosis time of the model could be 
improved, and the likelihood of misdiagnosis could be avoided. The DBN shows the 
disease progression at a population level and could suggest the most appropriate next 
step in the treatment process; the model here can be used as a prescriptive tool. Lastly, 
the aim is to develop a clinical-friendly model by taking into account other treatment 







Several limitations of the methods and tools described in this dissertation have been 
identified. The following sections discuss these limitations. 
1. The models and tools only support discrete nodes at present, due to a limitation 
of 
the learning and inference algorithms that are used.  
2. The algorithms also do not support continuous-time DBNs or DBN models 
with time slices of variable width. 
 
4.2.3 Future Research 
The extent to which DBNs can fulfil the objectives depends on the availability of 
accurate and complete datasets. In order to improve confidence in the network, more 
data is, in terms of several patients and length of records, needed to improve the 
confidence of the diagnosis path and discovery of new paths. Moreover, there is a need 
to include more variables besides the diagnosis. These variables include treatment, 
drugs and test results. The latter could improve the specificity of inference and diagnosis 
paths. 
 
The use of expert knowledge has been shown to be vital in various aspects of modelling, 
firstly in developing the structure of the network and also in estimating probabilities 
when data is incomplete, or some immeasurable variable needs to be included. Although 
automatic structure mining techniques are useful for defining relationships, these 
techniques cannot be used solely, without expert knowledge, especially with limited 
data. In future, the active involvement of the medical profession should be leveraged in 
creating the network structure and the data manipulation. 
 
We intend to build the model and tune it for online learning and online inferencing to 
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claims <- read.xlsx("~/Downloads/Chronic_Claims_Details_Actisure_updated.xlsx", 
sheet =3) 
df2 <- read.xlsx("~/Downloads/Chronic_Claims_Details_Actisure_updated.xlsx", sheet 
=2) 




















Total number of categories in the dataset:  
```{r warning=FALSE, echo=FALSE} 
cat("Total Claims \t",nrow(claims)) 
cat("\nUnique BENEFICIARYID \t", length(unique(claims$BENEFICIARYID))) 
cat("\nUnique FIRSTDIAGNOSIS \t", length(unique(claims$FIRSTDIAGNOSIS))) 
cat("\nUnique  SECONDDIAGNOSIS \t", 
length(unique(claims$SECONDDIAGNOSIS))) 
cat("\nUnique AFFECTEDSYSTEMDESC \t", 
length(unique(claims$AFFECTEDSYSTEMDESC))) 
cat("\nUnique RISKGROUPDESC \t", length(unique(claims$RISKGROUPDESC))) 
cat("\nUnique CLAIMYears \t", length(unique(claims$CLAIMDATE))) 
cat("\nUnique TREATMENTDESCRIPTION \t", 
length(unique(claims$TREATMENTDESCRIPTION))) 
cat("\nUnique SECTIONCODEDESC \t", 
length(unique(claims$SECTIONCODEDESC))) 























```{r warning=FALSE, echo=FALSE} 
 










































Total number of clients in the dataset 





```{r warning=FALSE, echo=FALSE} 
dff<-merge(x = claims, y = Chronic_background, by = "BENEFICIARYID", all.x = 
TRUE) 
dff$GENDER <- as.character(dff$GENDER) 
dff$GENDER[dff$GENDER == "F"] <- "FEMALE" 
dff$GENDER[dff$GENDER == "Female"] <- "FEMALE" 
dff$GENDER[dff$GENDER == "female"] <- "FEMALE" 
dff$GENDER[dff$GENDER == "Ms"] <- "FEMALE" 
dff$GENDER[dff$GENDER == "Male"] <- "MALE" 
dff$GENDER[dff$GENDER == "male"] <- "MALE" 
dff$GENDER[dff$GENDER == "M"] <- "MALE" 
 
#Chronic_background[Chronic_background$GENDER == 'F','GENDER'] <- "FEMALE" 
``` 
Though a majority of clients are born in the year 1980, they are distributed amoing the 
years with the youngest being 2016 







freqclaim<-claims %>%  
  select(BENEFICIARYID) %>%  
  group_by(BENEFICIARYID) %>%  
  summarise(claims = n()) %>% 


























freqclaim$DOB <- cut(x = as.numeric(freqclaim$DOB), breaks = c(1900, 1940, 1950, 




dff<-merge(x = claims, y = Chronic_background, by = "BENEFICIARYID", all.x = 
TRUE) 
dff$GENDER <- as.character(dff$GENDER) 
dff$GENDER[dff$GENDER == "F"] <- "FEMALE" 
dff$GENDER[dff$GENDER == "Female"] <- "FEMALE" 
dff$GENDER[dff$GENDER == "female"] <- "FEMALE" 
dff$GENDER[dff$GENDER == "Ms"] <- "FEMALE" 
dff$GENDER[dff$GENDER == "Male"] <- "MALE" 
dff$GENDER[dff$GENDER == "male"] <- "MALE" 
dff$GENDER[dff$GENDER == "M"] <- "MALE" 
 
wide<-bn.claims[,-1] 
wide <- reshape(wide, 
           idvar = "BENEFICIARYID", 
           timevar = "AFFECTEDSYSTEMDESC", 





























newdf <- claims.d[,c(-6,-8)] %>% 
  group_by(BENEFICIARYID) %>% 
  arrange(CLAIMDATE) %>% 
  mutate(replicate=seq(n())) %>% 
  mutate(freq=max(replicate)) %>% 
  filter (freq > 3) 
 
time1 <- newdf %>% 
  filter (freq > 3) %>% 
  filter (replicate == 1)  
   
write.csv(time1,"~/Dropbox/time1.csv") 
 
time2 <- newdf %>% 
  filter (freq > 3) %>% 




time3 <- newdf %>% 
  filter (freq > 3) %>% 





time4 <- newdf %>% 
  filter (freq > 3) %>% 




t12<-merge(time1, time2,  by="BENEFICIARYID") 
t123<-merge(t12, time3,  by="BENEFICIARYID") 
t1234<-merge(t123, time4,  by="BENEFICIARYID") 
write.csv(t1234,"~/Dropbox/t1234.csv") 
 
A3: Model Building 





datas <- BNDataset(data = cdatamat, discreteness = c(T,T,T,T, 
                                                     T,T,T,T, 
                                                     T,T,T,T, 
                                                     T,T,T,T),  num.time.steps = 4, na.string.symbol=NA, 
variables =  
                     c("FIRSTDIAGNOSIS","RISKGROUP","AGE","GENDER", 
                       "FIRSTDIAGNOSIS_1","RISKGROUP_1","AGE_1","GENDER_1", 
                       "FIRSTDIAGNOSIS_2","RISKGROUP_2","AGE_2","GENDER_2", 
                      "FIRSTDIAGNOSIS_3","RISKGROUP_3","AGE_3","GENDER_3"),  
                   node.size =c(228,33,6,2,224,36,6,2,227,35,6,2,243,36,6,2) ) 
 
# Define layers 


























# Build model 
layers <- c(3,2,1,1,3,2,1,1,3,2,1,1,3,2,1,1) 
 
dbnn <- learn.dynamic.network(datas, num.time.steps = 4,algo = "mmhc", scoring.func 
= "BIC", layering=layers,layer.struct=layerstruct, mandatory.edges=lay,custom=lay ) 
 
 








obs <- list("observed.vars" = c(1,3,4,5,7,8,11,12), 
 "observed.vals" = c(52,5,2,62,5,2,5,2)) 
engine <- InferenceEngine(dbnn) 
engine <- belief.propagation(engine, obs) 














obs <- list("observed.vars" = c(1,3,4,5,7,8,11,12), 
 "observed.vals" = c(87,5,2,92,5,2,5,2)) 
engine <- InferenceEngine(dbnn) 
engine <- belief.propagation(engine, obs) 

















obs <- list("observed.vars" = c(1,3,4,5,7,8,11,12), 
 "observed.vals" = c(87,4,1,62,4,1,4,1)) 
engine <- InferenceEngine(dbnn) 
engine <- belief.propagation(engine, obs) 






















obs <- list("observed.vars" = c(1,3,4,5,7,8,11,12), 
 "observed.vals" = c(102,4,1,112,4,1,4,1)) 
engine <- InferenceEngine(dbnn) 
engine <- belief.propagation(engine, obs) 


















obs <- list("observed.vars" = c(1,3,4,5,7,8,11,12), 
 "observed.vals" = c(52,3,1,196,3,1,3,1)) 
engine <- InferenceEngine(dbnn) 
engine <- belief.propagation(engine, obs) 
new.net <- updated.bn(engine) 
 
``` 
 
```{r} 
ccc<-cpts(new.net) 
dignosis1<-ccc[[9]] 
str(dignosis1) 
 
56 
 
 
 
ord<-order(matrix(dignosis1[196,,3,1]),decreasing=TRUE)[1:4] 
ord 
dignosis1[196,ord,3,1] 
``` 
 
 
